Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acute disseminated encephalomyelitis
adverse drug reaction
Alzheimer's disease
Alzheimer's disease, diagnosis of
Alzheimer's disease, preclinical
amyloid beta protein
amyloid imaging
amyloid plaques
asymptomatic
ataxia
biologic markers
brain biopsy
brain volume
brainstem
brainstem, lesion of
CAT scan
CAT scan, abnormal
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, mass effect on
CAT scan, ring sign
central nervous system, infection of
cerebellar lesion
cerebrospinal fluid, abnormal
cerebrospinal fluid, biochemical markers of CNS disease
cerebrospinal fluid, oligoclonal IgG in
cerebrovascular accident, young adult
children
Clinical Pathologic Conference(C.P.C.)
cognition
complications
corneal dystrophy
corpus callosum
corpus callosum, lesion of
cyclophosphamide
dementia
dementia, diagnostic evaluation of
dementia, early detection
dementia, presenile
demyelinating disease
disability rating scale, neurological
disability, neurological
disease modifying agents
efficacy
encephalomyelitis, postinfectious
enzyme, defect
Epstein-Barr virus
Fabry's disease
falling
fever
fingolimod
florbetapir
flu-like illness
fumarate
gait disorder
genetic neurologic disorders
hearing loss
hemiparesis
herpes virus
herpes virus infection
hippocampal atrophy
hippocampus
hypertension
immunomodulation
immunosuppressive agents
immunotherapy
interferon
interferon beta 1-a
interferon beta 1-b
L-dopa
leukoencephalopathy
leukopenia
liver function enzymes
lobar atrophy
Marburg's disease
McDonald criteria for MS
memory, impairment of
mild cognitive impairment
misdiagnosis
monoclonal antibodies
MRI
MRI, abnormal
MRI, demyelinating disease
MRI, functional
MRI, mass effect on
MRI, ring sign
MRI, volumetry
multiple sclerosis
multiple sclerosis, acute
multiple sclerosis, children
multiple sclerosis, clinical patterns
multiple sclerosis, diagnosis of
multiple sclerosis, diagnostic criteria
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, early onset
multiple sclerosis, etiology of
multiple sclerosis, misdiagnosis
multiple sclerosis, monosymptomatic
multiple sclerosis, MRI criteria
multiple sclerosis, presenting manifestations
multiple sclerosis, prognosis
multiple sclerosis, relapsing
multiple sclerosis, risk factors for
multiple sclerosis, spinal form
multiple sclerosis, treatment of
natalizumab
neoplasm, primary intracerebral
neoplasm, primary intracranial
neoplasm, primary of CNS
neoplasm, primary of CNS-children
neurologic disease, diagnoses of
neurosyphilis
nystagmus
old age, neurology of
optic neuritis
optic neuritis, bilateral
optic neuritis, children
optic neuritis, recurrent
Parkinson disease
Parkinson disease, late onset
Parkinson disease, treatment of
Parkinson disease, young onset
Pittsburgh Compound B
posterior fossa, lesion of
preclinical
prognosis
pseudotumor
review article
risk factors
safety
seizure
seizure, children
serologic testing
single photon emission computed tomography
slurred speech
somnambulism
spinal cord
spinal cord, enlargement
spinal cord, intramedullary cyst of
spinal cord, lesion of
spinal cord, neoplasm
spinal cord, neoplasm, infants and children
syphilis, diagnosis and treatment
syphilis, neurologic complications with
syringomyelia
temporal lobe, atrophy
tinnitus
treatment of neurologic disorder
uremia
urinary incontinence
urinary retention
vertigo
vertigo, episodic
viral infection
white matter disease
Showing articles 0 to 50 of 5295 Next >>

Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis
NEJM 379:1017-1027, Chitnis, T.,et al, 2018

Use of Newer Disease-Modifying Therapies in Pediatric Multiple Sclerosis in the US
Neurol 91:e1778-e1787, Krysko, K.M.,et al, 2018

An Expanded Role for Neuroimaging in the Evaluation of Memory Impairment
AJNR 34:2075-2082, Desikan, R.S.,et al, 2013

Longitudinal Change of Biomakers in Cognitive Decline
Arch Neurol 68:1257-1266,1237, Lo, R.Y.,et al, 2011

Safety and Efficacy of Natalizumab in Children With Multiple Sclerosis
Neurol 75:912-917, Ghezzi,A.,et al, 2010

A Comparison of MRI Criteria for Diagnosing Pediatric ADEM and MS
Neurol 74:1412-1415, 1404, Ketelslegers,I.A., et al, 2010

MRI in the Diagnosis of Pediatric Multiple Sclerosis
Neurol 72:961-967, Callen,D.J.A.,et al, 2009

Cyclophosphamide Therapy in Pediatric Multiple Sclerosis
Neurol 72:2076-2082,2064, Makhani,N.,et al, 2009

Natalizumab Use in Pediatric Multiple Sclerosis
Arch Neurol 65:1655-1658, Huppke,P.,et al, 2008

Natural History of Multiple Sclerosis with Childhood Onset
NEJM 356:2603-2613, Renoux,C.,et al, 2007

Dementia and White-Matter Demyelination in Young Patient With Neurosyphilis
Lancet:368:2258, Brinar,V.V. &Habek,M., 2006

Interferon beta-1a Treatment in Childhood and Juvenile-Onset Multiple Sclerosis
Neurol 67:511-513, Tenembaum,S.N. &Segura,M.J., 2006

Safety and Tolerability of Interferon Beta-1b in Pediatric Multiple Sclerosis
Neurol 66:472-476, Banwell,B.,et al, 2006

Treatment of Early Onset Multiple Sclerosis With Subcutaneous Interferon Beta-1a
Neurol 64:888-890, 778, Pohl,D., et al, 2005

Epstein-Barr Virus in Pediatric Multiple Sclerosis
JAMA 291:1875-1879, Alotaibi,S.,et al, 2004

Neuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future
Radiology 226:315-336, Petrella,J.R.,et al, 2003

Course and Prognosis in Early-Onset MS
Neurol 59:1922-1928, Simone,I.L., etla, 2002

Early Onset Multiple Sclerosis
Neurol 59:1006-1010, Boiko,A.,et al, 2002

Multiple Sclerosis in Children Under 6 Years of Age
Neurol 53:478-484, Ruggieri,M.,et al, 1999

Clinicopath Conf
Demyelinating Process Consistent with Multiple Sclerosis, Case 26-1998, NEJM 339:542-549998., , 1998

Risk Factors for Developing Multiple Sclerosis after Childhood Optic Neuritis
Neurol 49:11413-1418, Lucchinetti,C.F.,et al, 1997

Clinical, Neurodiagnostic, and MR Findings in Children with Spinal & Brain Stem Multiple Sclerosis
AJNR 16:87-95, Glasier,C.M.,et al, 1995

Tumoral Multiple Sclerosis of the Cerebellum in a Child
AJNR 16:1164-1166, Rusin,J.A.,et al, 1995

Does Ageing Aggravate Parkinsonisn Disability?
JNNP 54:780-782, Blin,J.,et al, 1991

Multiple Sclerosis in Adolescents:CT and MR Findings
AJR 155:385-390, Osborn,A.G.,et al, 1990

The Role of Nuclear Magnetic Resonance Imaging in the Diagnosis of MS in Childhood
Neurol 37:689-693, Golden,G.S.,et al, 1987

Multiple Sclerosis in Childhood:Clinical Profile in 125 Patients
J Pediatr 111:359-363, Duquette,P.,et al, 1987

Onset of Multiple Sclerosis in a 24-Month Old Child
Arch Neurol 41:881-882, Bejar,J.M.,et al, 1984

Childhood Multiple Sclerosis:Clinical Features & Demonstration of Changes in T Cell Subsets with Disease Act
Ann Neurol 11:463-468, Hauser,S.L.,et al, 1982

Demonstration of CSF Gamma-globulin Banding in Presenile Dementia
Neurol 30:882-884, Williams,A.,et al, 1980

Neurological Manifestations of Fabry Disease in Female Carriers
Ann Neurol 4:537-540, Bird,T.D.,et al, 1978

Neuro CPC of MGH
Acute Multiple Sclerosis, NEJM 273:760-7671965., , 1965

The Optic Nerve Should Graduate to Be the Fifth Lesion Site for the Diagnosis of Multiple Sclerosis
Neurol 102:e207919, Galetta,S. & Brownlee, W., 2024

Association of Very Early treatment Initiation with the Risk of Long-Term Disability in Patients with a First Demyelinating Event
Neurol 101:e1280-e1292, 549, Cobo-Calvo,A.,et al, 2023

Management of Possible Multiple Sclerosis
NEJM 388:2195-2190, , 2023

Endovascular vs Medical Management for Late Anterior Large Vessel Occlusion With Prestroke Disability
Neurol 100:e751-e763, Siegler, J.E., et al, 2023

Acute Flaccid Myelitis: Cause, Diagnosis, and Management
Lancet 394:334-397, Murphy, O.C.,et al, 2021

Melbourne Mobile Stroke Unit and Reperfusion Therapy
Stroke 51:922-930, Zhao, H.,et al, 2020

Application of the 2017 Revised McDonald Criteria for Multiple Sclerosis to Patients with a Typical Clinically Isolated Syndrome
JAMA Neurol 75:1392-1398, Van Der Vuurst De Vries, R.M.,et al, 2018

Inclusion of Optic Nerve Involvement in Dissemination in Space Criteria for Multiple Sclerosis
Neurol 91:e1130-e1134,545, Brownlee, W.J.,et al, 2018

Clinical Reasoning: A 49-year-old man with Progressive Numbness, Weakness, and Evidence of Leptomeningeal Enhancement
Neurol 90:e90-e93, Lovett, A.,et al, 2018

Neuromyelitis Optica Spectrum Disorder (NMOSD) in a Male with Hiccups and Quadriparesis
IJCMR 5:K28-K30, Tuteja,H.S.,et al, 2018

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
NEJM 376:209-220,280, Montalban, X.,et al, 2017

Intractable Epilepsy and Progressive Cognitive Decline in a Young Man
JAMA Neurol 74:737-740, Cohen, A.L.,et al, 2017

Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
NEJM 372:DOI:10.1056/NEJMoa1415061, DOI:10.1056 NEJM e1503217, Saver, J.L.,et al, 2015

Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke
NEJM 372:DOI:10.1056 NEJMoa1503780, DOI:1056NEJM e1503217, Jovin, T.G.,et al, 2015

Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
NEJM 372:2285-2295,2347, Saver, J.L.,et al, 2015

Thrombectomy within 8 hours after Symptom Onset in Ischemic Stroke
NEJM 372:2296-2306,2347, Jovin, T.G.,et al, 2015

Non-Alzheimers Dementia 1 Frontotemporal Dementia
Lancet 386:1672-1682, Bang, Jee.,et al, 2015



Showing articles 0 to 50 of 5295 Next >>